Jubilant Ingrevia

NSE: JUBLINGREABSE: 543271
Compare with peers
₹ 589.00▼ 43.35 (−6.86%)28 Oct, 03:29 pm IST
Market cap
₹ 9,649 Cr.
P/E
26.3x
P/B
3.07x
52-week range
537.3 – 795
ROE
10%
ROCE
11%
Dividend yield
0.8%
Debt / equity
0.25
Sector
Chemicals & Petrochemicals
Industry
Specialty Chemicals
Listed on
NSE, BSE

About

Jubilant Ingrevia Limited is a globally integrated life sciences and specialty chemicals company. Its segments include Specialty Chemicals, Nutrition & Health Solutions and Chemical Intermediates. The Specialty chemicals segment includes bio-pyridine & bio-picolines, fine chemicals, agro chemicals, custom development and manufacturing organization, and Microbial control solutions. The Nutrition & Health solutions segment includes nutrition and health ingredients and animal and human nutrition health solutions. The Chemical intermediates segment includes Acetyls and Specialty ethanol. In agro chemicals, it offers value-added derivatives, derived from specialty building blocks, such as amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines and so on. This sub-segment includes insecticides, herbicides and fungicides. In nutrition and health ingredients, it offers products like Vitamin B3 & Picolinates (Chromium & Zinc) which are fully backward integrated.

Quick check

The five things to look at first. Open one for more.

Compared with its industry

Specialty Chemicals: 130 companies →

Jubilant Ingrevia against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)26.3 against a typical 25.8: pricier than most peers (1st = cheapest).66th of 129
  • Sales growth+25.2% against a typical +25.9% from a year earlier.58th of 112
  • Profit growth+41.3% against a typical +42.4% from a year earlier.53rd of 102
  • Share price, 3 months−20.2% against a typical −5.8%.106th of 118
  • Size₹ 9,648.7 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).14th of 126

Latest announcements

Exchange filings and their impact on the company.

  • 27 Oct 2026Change in ManagementLow impactNeutralPrice +4.4% that day
    HR head Vinita Koul resigns effective 6 Nov 2026; no business impact expected.

    Jubilant Ingrevia said Ms. Vinita Koul, Sr. Vice President & Head HR, has resigned to pursue other interests, effective close of business on November 06, 2026. The company disclosed the resignation under Regulation 30 with no successor named yet. The change is limited to the HR function and is not expected to affect business operations or financials.

    Filing
  • 27 Oct 2026Outcome of Board MeetingMedium impactPositivePrice +4.4% that day
    Board approved Q2 and H1 FY27 results, keeping the recent sales and margin recovery on track.

    Jubilant Ingrevia's board on October 27, 2026 approved the unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The meeting ran from 11:10 a.m. to 2:00 p.m. and the results with limited review report were taken on record. The filing confirms the Q2 earnings update, which follows a strong Q1 with higher sales and margins.

    Filing
  • 13 Oct 2026General UpdatesLow impactNeutralPrice −0.1% that day
    Wholly-owned subsidiary Jubilant Advanced Electronics incorporated, with no immediate financial impact disclosed.

    Jubilant Ingrevia has incorporated its wholly-owned subsidiary, Jubilant Advanced Electronics Limited, on October 12, 2026 after approval from the Registrar of Companies. The filing follows its October 1, 2026 intimation about the proposed subsidiary and states all other particulars remain unchanged. No investment amount, capital or business plan was disclosed, so there is no immediate financial impact.

    Filing

Credit ratings

Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates

No up-to-date rating

AgencyCurrent ratingOutlookAs of
CRISIL——11 Aug 2026
India RatingsWithdrawnStable2 Dec 2025
Credit rating actions
RatingDetails
11 Aug 2026
Reaffirmed
——CRISIL₹ 600 Cr.
2 Dec 2025
Withdrawn
was IND AA+—India Ratings₹ 2,788.38 Cr.
12 Aug 2025
Reaffirmed
——CRISIL₹ 600 Cr.

Board meetings

Results dates and other board meetings. Full calendar

Details
27 Oct 2026Financial ResultsTo consider and approve the financial results for the period ended September 30, 2026
22 Jul 2026Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2026
26 May 2026Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2026 and dividend
4 Feb 2026Financial Results/DividendTo consider and approve the financial results for the period ended December 31, 2025 and dividend
27 Oct 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
31 Jul 2025Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2025

Share price

1M change −10.05%
1 of 2 filing days came with a big price moveBiggest +4.4% on 27 Oct 2026AI reading matched the move 1 of 1
Volume (shares)Price (₹)
Close price

Financials

Consolidated figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1,0209661,0741,0241,0451,0571,0511,0381,1211,0511,1791,300
Expenses9028719839159219189058969859241,0161,101
Operating Profit1189691110124138147142135126163199
OPM %12%10%8%11%12%13%14%14%12%12%14%15%
Other Income99101010981111−4910
Interest131514141512141312121217
Depreciation343436394040394141454851
Profit before tax8055516680961021009365112141
Tax %28%30%43%26%26%27%27%25%25%28%23%25%
Net Profit5739294959697475694786106
EPS in Rs3.612.421.843.063.74.364.654.714.362.945.436.64

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
—
5 Years
45%
3 Years
−3%
TTM
11%
Compounded Profit Growth
10 Years
—
5 Years
35%
3 Years
−2%
TTM
15%
Stock Price CAGR
10 Years
—
5 Years
1%
3 Years
18%
TTM
—
Return on Equity
10 Years
—
5 Years
11%
3 Years
8%
TTM
—

Shareholding

Latest: Jun 2026.

Promoters
45.22%
0 pts in a year
FIIs
6.49%
−0.47 pts in a year
DIIs
24.98%
+3.17 pts in a year
Government
0.02%
+0.02 pts in a year
Public
22.3%
−3 pts in a year
Others
0.98%
+0.26 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 26.3xEPS (12 months) ₹ 22.60Median P/E 36.9x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Jubilant Ingrevia₹ 589.00₹ 9,649 Cr.26.3x3.1x10%—
Asian Paints₹ 2,305.00₹ 2,21,095 Cr.58.1x12.1x21.2%12.4%
Solar Industries India₹ 18,320.00₹ 1,65,778 Cr.99.6x26.6x31.4%17.7%
Pidilite Industries₹ 1,514.00₹ 1,54,107 Cr.64.8x14.7x23.8%16.9%
SRF₹ 2,309.00₹ 68,444 Cr.44.6x6.1x13.8%11.6%
Linde India₹ 5,697.00₹ 48,586 Cr.110.5x14.2x13.6%21.7%

Management

Hari Shanker Bhartia
Executive Co-Chairman of the Board
Varun Gupta
President, Chief Financial Officer
Deepak Jain
Chief Executive Officer, Managing Director, Executive Director
Vijay Kumar Srivastava
Chief of Operations, Whole-Time Director
Vinita Koul
Senior Vice President, Head - Human Resources
Deepanjali Gulati
Compliance Officer, Company Secretary

Prices are delayed and for information only. Nothing on this page is investment advice.